Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Gq/11α and Gsα mediate distinct physiological responses to central melanocortins
Yong-Qi Li, … , Stefan Offermanns, Lee S. Weinstein
Yong-Qi Li, … , Stefan Offermanns, Lee S. Weinstein
Published November 23, 2015
Citation Information: J Clin Invest. 2016;126(1):40-49. https://doi.org/10.1172/JCI76348.
View: Text | PDF
Research Article Metabolism

Gq/11α and Gsα mediate distinct physiological responses to central melanocortins

  • Text
  • PDF
Abstract

Activation of brain melanocortin 4 receptors (MC4Rs) leads to reduced food intake, increased energy expenditure, increased insulin sensitivity, and reduced linear growth. MC4R effects on energy expenditure and glucose metabolism are primarily mediated by the G protein Gsα in brain regions outside of the paraventricular nucleus of the hypothalamus (PVN). However, the G protein(s) that is involved in MC4R-mediated suppression of food intake and linear growth, which are believed to be regulated primarily though action in the PVN, is unknown. Here, we show that PVN-specific loss of Gqα and G11α, which stimulate PLC, leads to severe hyperphagic obesity, increased linear growth, and inactivation of the hypothalamic-pituitary-adrenal axis, without affecting energy expenditure or glucose metabolism. Moreover, we demonstrate that the ability of an MC4R agonist delivered to PVN to inhibit food intake is lost in mice lacking Gq/11α in the PVN but not in animals deficient for Gsα. The blood pressure response to the same MC4R agonist was only lost in animals lacking Gsα specifically in the PVN. Together, our results exemplify how different physiological effects of GPCRs may be mediated by different G proteins and identify a pathway for appetite regulation that could be selectively targeted by Gq/11α-biased MC4R agonists as a potential treatment for obesity.

Authors

Yong-Qi Li, Yogendra Shrestha, Mritunjay Pandey, Min Chen, Ahmed Kablan, Oksana Gavrilova, Stefan Offermanns, Lee S. Weinstein

×

Figure 7

AAV-PVNGq/11KO mice are hyperphagic and obese.

Options: View larger image (or click on image) Download as PowerPoint
AAV-PVNGq/11KO mice are hyperphagic and obese.
(A) Representative image ...
(A) Representative image (original magnification, ×10; scale bar: 200 μM) showing fluorescence localized to PVN at 10 weeks after bilateral injection of AAV-Cre-GFP. (B) PVN mRNA levels of Gqα (Gnaq), Mc4r, Crh, and Sim1 measured 10 weeks after viral injection in AAV-PVNGq/11KO and control mice (n = 4 per group). (C) Body weight of AAV-PVNGq/11KO and control mice measured before and 10 weeks after viral injection (n = 6 per group). (D) Daily food intake of AAV-PVNGq/11KO and control mice measured 4 weeks after viral injection (n = 6 per group). Data are expressed as mean ± SEM. *P < 0.05 vs. controls by Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts